Qube Research & Technologies LTD Merck & Co., Inc. Transaction History
Qube Research & Technologies LTD
- $65.7 Billion
- Q3 2024
A detailed history of Qube Research & Technologies LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 4,172,845 shares of MRK stock, worth $420 Million. This represents 0.72% of its overall portfolio holdings.
Number of Shares
4,172,845
Previous 4,275,083
2.39%
Holding current value
$420 Million
Previous $529 Million
10.47%
% of portfolio
0.72%
Previous 0.85%
Shares
27 transactions
Others Institutions Holding MRK
# of Institutions
3,824Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$25.1 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$12 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.63 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.95 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $255B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...